Cite
HARVARD Citation
Samaan, M. et al. (2017). Vedolizumab: early experience and medium-term outcomes from two UK tertiary IBD centres. Frontline gastroenterology. 8 (3), pp. 196-202. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Samaan, M. et al. (2017). Vedolizumab: early experience and medium-term outcomes from two UK tertiary IBD centres. Frontline gastroenterology. 8 (3), pp. 196-202. [Online].